How ResMed Trounced Expectations in Q4

There were plenty of questions earlier this year about how the COVID-19 pandemic might impact ResMed (NYSE: RMD). It's fair to say that most of the concerns have been put to rest. ResMed's shares are up more than 20% year to date.

The company announced its fiscal 2020 fourth-quarter results after the market closed on Wednesday. Here are the highlights from ResMed's Q4 update.

Image Source: Getty Images.

Source Fool.com